Bubble Intelligence
Market Intelligence For The New Regime
AI CAPEX Monitor
Supply Chain Data
Companies
About
Back to Dashboard
REGENERON PHARMACEUTICALS, INC.
REGN
regeneron.com
Latest Filing: Apr 29, 2026 • 25 Total Filings
Total Assets
2026
$40.87B
Total Revenue
2026
$3.61B
Net Income
2026
$727.20M
Operating Cash Flow
2026
$1.08B
Overview
Supply Chain
Financials
Narratives
Legal Identity
Error
Failed to load Business Overview for REGN